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OBJECTIVE—To determine whether HHEX-IDE and CDKAL1
genes, which are associated with birth weight and susceptibility
to type 2 diabetes, continue to inﬂuence growth during
childhood.
RESEARCH DESIGN AND METHODS—BMI, weight, and
height at age 8 years expressed as age- and sex-corrected
standard deviation scores (SDS) against national reference data
and single-nucleotide polymorphism genotyping of HHEX-IDE
and CDKAL1 loci were analyzed in 646 prospectively followed
children in the German BABYDIAB cohort. All children were
singleton full-term births; 386 had mothers with type 1 diabetes,
and 260 had fathers with type 1 diabetes and a nondiabetic
mother.
RESULTS—Type 2 diabetes risk alleles at the HHEX-IDE locus
were associated with reduced BMI-SDS at age 8 years (0.17 SDS
per allele; P  0.004). After stratiﬁcation for birth weight, both
HHEX-IDE and CDKAL1 risk alleles were associated with
reduced BMI-SDS (0.45 SDS, P  0.0002; 0.52 SDS, P  0.0001)
and weight-SDS (0.22 SDS, P  0.04; 0.56 SDS, P  0.0002) in
children born large for gestational age (90th percentile) but
not children born small or appropriate for gestational age.
Within children born large for gestational age, BMI and weight
decreased with each additional type 2 diabetes risk allele ( 2
kg per allele; 8 kg overall). Findings were consistent in children
of mothers with type 1 diabetes (P  0.0001) and children of
nondiabetic mothers (P  0.008).
CONCLUSIONS—The type 2 diabetes susceptibility alleles at
HHEX-IDE and CDKAL1 loci are associated with low BMI at age
8 years in children who were born large for gestational age.
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G
enome-wide association studies have recently
identiﬁed common, novel type 2 diabetes sus-
ceptibility loci that are likely to predispose one
to diabetes via impaired pancreatic -cell func-
tion, impaired insulin secretion, and/or insulin sensitivity
(1–3). Some effects occur during fetal growth. For exam-
ple, the presence of type 2 diabetes risk alleles at the
HHEX-IDE and CDKAL1 loci are associated with reduced
birth weight, consistent with reduced insulin responses
during fetal development (4). This was also observed for
the HHEX-IDE locus in our studies of children born to
mothers with type 1 diabetes where the fetus is exposed to
high and variable glucose concentrations (5). It is un-
known whether the gene effects during fetal life persist
and whether they are acting in a similar manner after birth.
Here we partially address this by determining whether the
type 2 diabetes risk alleles at the HHEX-IDE and CDKAL1
loci are associated with growth during childhood in a
cohort of children whose mothers or fathers had type 1
diabetes.
RESEARCH DESIGN AND METHODS
Children of parents with type 1 diabetes were recruited in Germany between
1989 and 2000 in the context of the BABYDIAB study (6). Relevant to the
current study, birth as well as weight and height data during follow-up were
collected from pediatric records that were completed by trained staff at
delivery and by pediatricians at visits to the clinic after birth. Children from
singleton full-term (37 weeks gestational age) births who had a pediatric
visit as part of the study between the age of 7.5 and 8.5 years were included
in the current analysis. Of these 731 children, genetic data, weight, and height
were available from 646 children. This included 386 children who had a
mother with type 1 diabetes and 260 children who had a father with type 1
diabetes and a nondiabetic mother. None of the children had a mother with
known gestational diabetes. Children who had developed type 1 diabetes prior
to age 8 years were not included, because they were lost to follow-up at the
onset of their diabetes. All families gave written informed consent to
participate in the BABYDIAB study. The study was approved by the ethical
committee of Bavaria, Germany (Bayerische Landesa ¨rztekammer Nr. 95357).
All children were genotyped for the CDKAL1 SNP rs4712526 and HHEX-
IDE SNP rs5015480, rs10882102, and as a control for a type 2 diabetes
susceptibility gene that is not associated with fetal growth, also the SLC30A8
SNP rs3802177. Genotyping was performed with the MassARRAY system
using the iPLEX chemistry (Sequenom, San Diego, CA) as previously de-
scribed (5). To control for reproducibility, 16.3% of samples were genotyped
in duplicate with discordance rate 0.5%. All SNPs were shown to be in
Hardy-Weinberg equilibrium by means of Fisher exact test.
Homeostasis model assessment of insulin resistance (HOMA-IR) was
obtained in a subset of children at age 8 years. Children were asked to fast for
at least 8 h. Fasting blood glucose was determined locally by a pathology
laboratory. Fasting insulin was determined centrally using the Mercodia
Ultrasensitive Insulin ELISA (Uppsala, Sweden), a solid-phase two-site en-
zyme immunoassay, as described in the manufacturer’s instructions.
For analysis, data on height, weight, and BMI at follow-up were adjusted
for sex and exact age at examination and were expressed as standard
deviation scores (SDS) from the mean using German reference data derived
from over 34,000 children (7,8). The association between weight-SDS, height-
SDS, BMI-SDS, and genotype for each SNP was examined using linear
regression, with genotypes coded as 0, 1, or 2 risk alleles and, as a covariate,
the type 1 diabetes status of the mother when appropriate. Interaction
between birth weight and the HHEX-IDE or CDKAL1 genotypes was tested by
the general linear model. Data were also stratiﬁed for birth weight expressed
as percentiles of the reference German population adjusted for sex and
gestational age (9) using the categories small for gestational age (SGA; birth
weight 10th percentile of the reference population; n  68), appropriate for
gestational age (AGA; 10th–90th percentile of the reference population; n 
459), and large for gestational age (LGA; 90th percentile of the reference
population; n  120). Gestational age and sex distribution was similar among
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SPSS 17.0 (SPSS Inc, Chicago, IL).
RESULTS
Weight, height, and BMI at age 8 years in the cohort were
normally distributed and were not signiﬁcantly different to
those of the German reference data (Supplementary Fig.
S1, available in an online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db10-0099/DC1, and
Table 1). No differences were observed for weight, height,
and BMI at age 8 years between children who had a
mother with type 1 diabetes and children who had a father
with type 1 diabetes and a nondiabetic mother (Table 1).
The type 2 diabetes risk allele at the HHEX-IDE locus
was associated with reduced BMI-SDS at age 8 years in all
children. Per risk allele, the BMI-SDS was lower by 0.17
SDS (95% CI, 0.06–0.28; P  0.004) at age 8 years (Table 2).
The association remained signiﬁcant when the child’s
maternal diabetes status was included as a covariate (P 
0.004). The same association was observed when a second
SNP within the HHEX-IDE locus (rs10882102) was exam-
ined (data not shown). The genotypes at the CDKAL1 and
SLC30A8 loci were not signiﬁcantly associated with BMI-
SDS in the total cohort.
Joint regression analysis showed that 8-year BMI was
associated with both birth weight percentile (P  0.0001)
and the HHEX-IDE gene (P  0.01) also when adjusted for
maternal diabetes status. We therefore stratiﬁed the chil-
dren on the basis of their gestational age- and sex-
corrected birth weight percentile into small (10th
percentile), appropriate (10th–90th percentile) and large
(90th percentile) for gestational age and analyzed the
BMI–gene relationships. Strikingly, there was a very
strong association between BMI and the HHEX-IDE geno-
types in the LGA children (P  0.0003), but not in the SGA
and AGA children (Fig. 1A; supplementary Tables S1–S3 in
an online appendix). A similar association was also ob-
served with CDKAL1 genotypes (P  0.0001, Fig. 1B;
supplementary Tables S1–S3). For CDKAL1, signiﬁcant
interaction was shown between birth weight category and
genotype in the general linear model (P  0.01). For both
genes, the type 2 diabetes susceptibility genes were asso-
ciated with lower BMI-SDS at age 8 years in children born
LGA, with the strongest effects seen in children who were
TABLE 1
Characteristics of the study cohort
Children of mothers
with T1D
Children of fathers
with T1D† All children
n (% male) 386 (48.6) 260 (52.7) 646 (50.2)
Median (IQR) gestation in weeks (range) 39 (38–40) 40 (39–41) 39 (38–40)
Birth weight, g 3,572.5  579 3,465.4  510 3,527.6  553
Median (IQR) birth weight percentile (range) 68 (33–91) 54 (23–74) 60 (28–85)
SGA* 35 (9.1) 33 (12.7) 68 (10.5)
AGA* 256 (66.3) 203 (78.1) 459 (71.1)
LGA* 95 (24.6) 24 (9.2) 119 (18.4)
Birth length, cm 51.2  2.7 51.8  2.4 51.5  2.6
8-year height, cm 131.1  5.6 131.8  5.6 131.4  5.6
8-year height-SDS 0.23  0.96 0.35  0.96 0.28  0.96
8-year weight, kg 28.2  4.8 28.5  5.1 28.4  4.9
8-year weight-SDS 0.11  0.93 0.16  0.95 0.13  0.94
8-year BMI 16.4  2.1 16.3  2.2 16.4  2.2
8-year BMI-SDS 0.01  1.0 0.03  1.0 0.01  1.0
Data are mean  SD or n (%). *SGA, small for gestational age (10th percentile); AGA, appropriate for gestational age (10th–90th percentile);
LGA, large for gestational age (90th percentile). †Children of fathers with type 1 diabetes (T1D) had a mother without T1D or known other
diabetes.
TABLE 2
BMI-SDS at age 8 years in relation to fetal genotype in children of parents with type 1 diabetes
BMI-SDS, mean (95% CI) Effect per allele
BMI-SDS
(95% CI) §P †P adjusted
Fetal genotype
(no. of T2D risk alleles)
Locus 0 1 2
HHEX-IDE 0.25 (0.06–0.45) 0.04 (0.15–0.08) 0.12 (0.26–0.01) 0.17 (0.06–0.28) 0.004 0.004
n  104 n  318 n  218
CDKAL1 0.11 (0.13–0.34) 0.05 (0.17–0.07) 0.01 (0.13–0.11) 0.03 (0.14–0.09) 0.67 0.69
n  74 n  284 n  88
SLC30A8 0.08 (0.20–0.35) -0.09 (0.21–0.03) 0.02 (0.09–0.14) 0.03 (0.09–0.16) 0.60 0.54
n  54 n  277 n  305
Birth weight SGA AGA LGA
0.33 (0.57–0.10) 0.06 (0.15–0.03) 0.32 (0.15–0.49) 0.001 0.001
n  70 n  507 n  132
§The association BMI-SDS and genotype for each SNP was examined using linear regression, with genotypes coded as 0, 1, or 2 risk alleles.
The association BMI-SDS and birth weight was examined using linear regression, with birth weight coded as SGA (small for gestational age;
10th percentile), AGA (appropriate for gestational age; 10th–90th percentile), or LGA (large for gestational age; 90th percentile).
†Adjusted for proband (children who have a mother with type 1 diabetes or children without a mother with type 1 diabetes).
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the BMI-SDS was lower by 0.45 SDS (95% CI, 0.22–0.69) for
the HHEX-IDE gene and by 0.52 SDS (95% CI, 0.26–0.78)
for the CDKAL1 gene in the LGA children. For both the
HHEX-IDE and the CDKAL1 genes, a mean BMI above the
German reference population mean at 8 years was ob-
served only in the subgroup of children who were LGA and
not homozygous for the type 2 diabetes susceptibility
alleles. A similar relationship was observed between the
HHEX-IDE and the CDKAL1 genes and weight but not
height (supplementary Tables S4 and S5, available in an
online appendix). No relationship between alleles of the
SLC30A8 gene and BMI-SDS were observed with or with-
out stratiﬁcation for birth weight (data not shown).
Within the LGA group, both genes were associated with
BMI at age 8 years (HHEX-IDE, P  0.0001; CDKAL1, P 
0.0002) with an adjusted R
2 of 0.21 in the joint regression
model. Thus, the combination of alleles from both genes
showed a dramatic association between the number of
type 2 diabetes susceptibility alleles and lower BMI in LGA
children (Fig. 2, supplementary Figure S2A and supple-
mentary Table S6, available in an online appendix). LGA
children with no type 2 diabetes susceptibility alleles at
the HHEX-IDE and CDKAL1 loci had BMIs almost two
SDS above the population average, whereas children who
had four susceptibility alleles had BMIs that were at or
below the population average. Across all birth weight
strata, an increased mean 8-year BMI was only seen in
children who were LGA and had two or less of the type
2 diabetes susceptibility alleles for HHEX-IDE and
CDKAL1. These ﬁndings were consistent in children who
had a mother with type 1 diabetes (P  0.0001) and
children who had a father with type 1 diabetes and a
nondiabetic mother (P  0.008), and no evidence of
interaction between maternal diabetes status and geno-
type on 8-year BMI was observed. Examination of weight
and height in relation to these gene combinations in LGA
children found an association with weight and weight-SDS
(P  0.0002; supplementary Figure S2B and supplemen-
tary Table S7, available in an online appendix) correspond-
ing to a weight difference of  2 kg per risk allele and
resulting in 8 kg difference between LGA children with
no risk alleles (mean weight, 35.7 kg) and those with all
four risk alleles (mean weight, 27.5 kg). No association
was observed with height-SDS (P  0.51; data not shown).
HOMA-IR was available at age 8 years in 63 LGA children.
With this limited data, a similar, but not signiﬁcant, trend
was observed between the number of type 2 diabetes
susceptibility alleles at the HHEX-IDE and CDKAL1 loci
and both fasting insulin and HOMA-IR (supplementary
Figure S3, available in an online appendix).
DISCUSSION
An association between the recently identiﬁed type 2
diabetes susceptibility genotypes and growth during child-
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a cohort of children showed that type 2 diabetes suscep-
tibility genotypes at the HHEX-IDE and CDKAL1 loci
were associated with reduced BMI and weight at age 8
years. The associations were interactive with birth weight
status, suggesting that these genes contribute to both fetal
and childhood growth patterns.
Previous studies (10–16) have shown that birth weight
is associated with growth and BMI during childhood.
Consistent with these studies, SGA children in our cohort
were 2 kg lighter and LGA children were 2 kg heavier
than AGA children at age 8 years (data not shown). There
was, however, also a very striking relationship between
the HHEX-IDE and CDKAL1 genotypes and 8-year BMI
that was found in LGA children. Both genes contributed
independently to reduce BMI and weight to around normal
in the LGA children but not in the AGA children. Thus, our
ﬁndings suggest that the type 2 diabetes susceptibility
genes HHEX-IDE and CDKAL1 inﬂuence homeostasis of
body mass when there has been excessive fetal growth.
Potentially relevant to this afﬁrmation is that over half the
children in our cohort were affected by maternal diabetes,
a state that is associated with increased fetal growth via
mechanisms that include increased fetal insulin produc-
tion (17). These children are no longer exposed to diabetic
glycemic variations after delivery and are therefore inter-
esting to compare to children of nondiabetic mothers. In
this regard, the associations between the HHEX-IDE and
CDKAL1 genes and 8-year BMI were consistent in LGA
children from mothers with diabetes and children who had
a father with type 1 diabetes and a mother without known
diabetes. Therefore, although it cannot be excluded that
the LGA children from the nondiabetic mothers were also
exposed to hyperglycemic stimuli during fetal growth, the
associations between genes and BMI appear to be inde-
pendent of hyperglycemia during pregnancy, further sup-
porting the notion that the genes inﬂuence childhood
growth in addition to fetal growth.
Our ﬁndings are inconsistent with a recent report on
children (18). Zhao et al. found increased BMI associated
with the type 2 diabetes susceptibility allele of the HHEX-
IDE gene and no association between BMI and SNPs of the
CDKAL1 gene. It should be noted that, in their study, the
association between increased BMI and the HHEX-IDE
gene was only observed in children aged 2–6 years and not
in older children, whereas we examined children at the
age of 8 years. Moreover, inconsistent with ours and other
studies (4,5), they did not ﬁnd an association between the
HHEX-IDE gene and birth weight in their cohort. Finally,
because our associations were limited to children who
were LGA, it is possible that these would be missed in a
cohort that is not overly represented by LGA children.
The relationship of our ﬁndings to type 2 diabetes
susceptibility and pathogenesis is unclear. Many have
shown that SGA is associated with increased type 2
diabetes risk (19–22), and some have also suggested that
LGA is associated with increased risk (23–25). The rela-
tionship of type 2 diabetes susceptibility genes with
growth and BMI appears complex, and there is no general
rule for the direction of the effect of type 2 diabetes
susceptibility and BMI. Ours and previous studies consis-
tently show that SGA is associated with reduced weight,
height, and BMI during childhood (10–16). Our data fur-
ther show that having the full complement of type 2
diabetes susceptibility genotypes for two genes protects
against increased BMI at age 8 years. Analogous to this,
the protective variant of the type 2 diabetes susceptibility
gene PPARG2 is associated with increased BMI (26–28).
Thus, while type 2 diabetes is generally associated with
increased BMI, there are examples where increased BMI
can be associated with reduced type 2 diabetes risk. It is
possible that, in such examples, large fat deposits may
protect against accumulation in the liver and muscle in
children with protective alleles. It is also possible that,
although BMI is not increased, other characteristics such
as adiposity or insulin sensitivity may be already affected
in the children (29,30), or that different gene effects are
seen in the subset of children with increased adiposity (28)
or under certain dietary conditions such as was found for
peroxisome proliferator–activated receptor- (31). Rele-
vant to our cohort, which has an increased load of type 1
diabetes–associated genetic susceptibility, it is possible
that the relative contribution of genes such as HHEX-IDE
and CDKAL1 to pathogenesis may be outweighed by a
series of other genes. Finally, longer follow-up of our and,
in particular, type 2 diabetes–susceptible cohorts will be
required to ascertain if the association of lower weight and
BMI with the type 2 diabetes susceptible alleles for the
HHEX-IDE and CDKAL1 genes persists or changes after
puberty and in adulthood.
In conclusion, we show that the fetal programming
associated with the type 2 diabetes susceptibility genes
HHEX-IDE and CDKAL1 has prolonged effects during
childhood as evidenced by the inﬂuence of birth weight
status on BMI and weight at age 8 years, and that further
programming in association with these genes occurs dur-
ing childhood when there has been excess fetal growth.
These data indicate that there is important genetic control
of childhood weight that may act through mechanisms
associated with insulin release and action. The relation-
ship of these genetic factors to weight control during
childhood appears inconsistent to their association with
type 2 diabetes later in life, a ﬁnding that requires valida-
tion and longer follow-up of cohorts that are susceptible
for type 2 diabetes.
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